ProCE Banner Activity

NAMSAL: Wk 192 Results of Dolutegravir-Based vs Low-Dose Efavirenz-Based Regimens as First-line ART in Cameroon

Slideset Download
Conference Coverage
Both DTG 50 mg plus 3TC/TDF and EFV 400 mg plus 3TC/TDF regimens effective and safe for treatment-naive PWH in Cameroon, with higher rates of virologic suppression over time and more weight gain observed with DTG-based regimen.

Released: August 02, 2022

Expiration: August 01, 2023

Begin Activity


Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare


IAS 2021

ProCE Banner